NCT
HOME CURRENT ARCHIVE COVID-19
HOME CURRENT ARCHIVE PUBLISH INSTRUCTIONS
FOR AUTHORS COVID-19 LOG IN / REGISTER HISTORY ABOUT US DIRECTORY CONTACT
Diagnostic examination in pulmonary hypertension of the adult

Flores-Franco, René Agustín , Frías-Fierro, Daniel Arturo





2019, Number 3

2019; 78 (3)






ABSTRACT

Despite technological advances in the diagnosis of pulmonary hypertension, medical history and physical examination are still considered fundamental as screening method provided the theoretical aspects, their foundations and their limitations are mastered. With the identification of the risk factors, the exclusion of those entities that are part of the differential diagnosis, an adequate auscultation and the analysis of the set of clinical variables obtained, provides important clues that could assist in the detection as early as possible of the disease or contribute to the follow-up of these patients.

KEYWORDS

Pulmonary hypertension, physical examination, right-sided heart failure, right ventricle.

REFERENCES

  1. Peacock AJ. The diagnosis of pulmonary hypertension. Clinical features. In: Peacock AJ, Rubin LJ, editors. Pulmonary circulation. Diseases and their treatment. 2a ed. New York: Arnold publishers; 2004.p.73.

  2. Galiè N, McLaughlin VV, Rubin LJ, Simonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J 2019;53(1).pii1802148. https://doi.org/10.1183/13993003.02148-2018.

  3. Guadalajara-Boo JF. La auscultación del corazón, un arte en vías de extinción. Gac Med Mex 2015;151(2):260-265.

  4. Patil S, Henry JW, Rubenfire M, Stein PD. Neural network in the clinical diagnosis of acute pulmonary embolism. Chest 1993;104(6):1685-1689. https://doi.org/10.1378/chest.104.6.1685.

  5. Freeman LM, Krynyckyi B, Zuckier LS. Enhanced lung scan diagnosis of pulmonary embolism with the use of ancillary scintigraphicfinfdings and clinical correlation. Semin Nucl Med 2001;31(2):143-157.

  6. Colman R, Whittingham H, Tomlinson G, Granton J. Utility of the physical examination in detecting pulmonary hypertension. A mixed methods study. PLoSOne 2014;9(10):e108499. https://doi.org/10.1371/journal.pone.0108499.

  7. Marcus GM, Vessey J, Jordan MV, et al. Relationship between accurate auscultation of a clinically useful third heart sound and level of experience. Arch Intern Med 2006;166(6):617-622. https://doi.org/10.1001/archinte.166.6.617.

  8. Flores-Franco RA. La auscultación como metodología diagnóstica. En: Flores-Franco RA, Gómez-Sáenz LM, editores. La estetoscopia. Teoría, práctica y enseñanza-aprendizaje. México: Trillas; 2018.p.29.

  9. Granton JT, Whittingham H, Tomlinson G, et al. Does this patient have pulmonary hypertension? A prospective evaluation of the utility of the physical examination. Am J Respir Crit Care Med 2010;181:A3372. https://doi.org/10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A3372-

  10. Fraser AG, Weston CF. The Graham Steell murmur: eponymous serendipity? J R Coll Physicians Lond 1991;25(1):66-70.

  11. Hui-Li G. The management of acute pulmonary arterial hypertension. CardiovascTher 2011;29(3):153-175. https://doi.org/10.1111/j.1755-5922.2009.00095.x.

  12. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: Increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000;83(3):416-420.

  13. Stein PD. Relation of right-sided pressures to clinical characteristics of patients with no prior cardiopulmonary disease. In: Stein PD, editor. Pulmonary embolism. 3rd ed. Oxford, UK: Wiley Blackwell; 2016.p. 272-274.

  14. Stein PD, Beemath A, Matta F, et al. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med 2007;120(10):871-879.

  15. Light RW. Pleural effusion due to pulmonary emboli. CurrOpinPulm Med2001;7(4):198-201.

  16. Stein PD. Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes. In: Stein PD, editor.Pulmonary embolism. 3rd ed. Oxford, UK: Wiley Blackwell; 2016.p. 280-285.

  17. Riedel M. Diagnosing pulmonary embolism. Postgrad Med J 2004;80(944):309-319.

  18. Lobo-Beristáin JL, Egea-Santaolalla C. Síndromes clínicos de embolia pulmonar. Semin Fund Esp Reumatol 2006;7(3):139-146. doi: 10.1016/S1577-3566(06)75092-8.

  19. Hughes MJ, Stein PD, Matta F. Silent pulmonary embolism in patients with distal deep venous thrombosis: systemic review. Thromb Res 2014;134(6):1182-1185. https://doi.org/10.1016/j.thromres.2014.09.036.

  20. Hill NS. The cardiac exam in lung disease. Clin Chest Med 1987;8(2):273-285.

  21. Don Michael TA. Eliciting heart sounds: timing, amplitude, and pitch. In: Don Michel TA, editor. Auscultation of the heart. A cardiophonetic approach. New York, USA: McGraw-Hill; 1998.p.113-160.

  22. Mauritz GJ, Marcus JT, Westerhof N, Postmus PE, Vonk-Noordegraaf A. Prolonged right ventricular post-systolic isovolumic period in pulmonary arterial hypertension is not a reflection of diastolic dysfunction. Heart 2011;97(6):473-478. https://doi.org/10.1136/hrt.2010.193375.

  23. Fraser RS, Lynne-Davies P. Continuous chest murmur acquired following pulmonary thromboembolism. Chest 1974;65:562-564.

  24. ZuWallack RL, Liss JP, Lahiri B. Acquired continuous murmur associated with acute pulmonary thromboembolism. Chest 1976;70(4):557-559. https://doi.org/10.1378/chest.70.4.557.

  25. Santos-Martínez LE. Fisiopatología de la falla ventricular derecha en la hipertensión arterial pulmonar. Arch Cardiol Mex 2004;74(Supl 2):S353-S357.

  26. Renshaw SA, SR Brennan, Heigenbottam TW. The clinical presentation of deep vein thrombosis and pulmonary thromboembolism. In: Oudkerk M, van Beek EJR, ten Cate JW, editors. Pulmonary embolism. Oxford, UK: Blackwell Science; 1999.p.34-42.

  27. Shank-Coviello J. Fundamentos de los soplos. En Shank-Coviello J, editor. Manual interactivo de auscultacióncardíaca y respiratoria. 5a ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins; 2016.p.56-78.

  28. Stein PD, Matta F, Musani MH, Diaczok B. Silent pulmonary embolism in patients with deep venous thrombosis: a systemic review. Am J Med 2010;123(5):426-431. https://doi.org/10.1016/j.amjmed.2009.09.037.

  29. Sharma GV, Sasahara AA. Diagnosis and treatment of pulmonary embolism. Med Clin North Am 1979;63(1):239-250.

  30. Manganelli D, Palla A, Donnamaria V, Giuntini C.Clinical features of pulmonary embolism. Doubts and certainties. Chest 1995;107(1 Suppl):25S-32S. https://doi.org/10.1378/chest.107.1_supplement.25s.

  31. Simonneau G, Galiè N, Rubin L, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43(12 Suppl):S5-S12.

  32. Maron BA, Choudhary G, Kahn UA, et al. The clinical profile and underdiagnosis of pulmonary hypertension in US veteran patients. CircHeart Fail 2013;6(5):906-912. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000091.

  33. Deaño RC, Glassner-Kolmin C, Rubenfire M, et al. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. JAMA Intern Med 2013;173(10):887-893. https://doi.org/10.1001/jamainternmed.2013.319.

  34. Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev 2010;19(115): 59-63. https://doi.org/10.1183/09059180.00007309.

  35. Lai YC, Potoka KC, Champion HC, Mora AL, Gladwin MT. Pulmonary arterial hypertension: the clinical syndrome.Circ Res 2014;115(1):115-130. https://doi.org/10.1161/CIRCRESAHA.115.301146.

  36. Matura LA, Shou H, Fritz JS, et al. Physical activity and symptoms in pulmonary arterial hypertension. Chest 2016;150(1):46-56.https://doi.org/10.1016/j.chest.2016.02.633

  37. Delcroix M, Howard L. Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Eur Respir Rev 2015;24:621-629.

  38. Dumitrescu D, Sitbon O, Weatherald J, Howard LS. Exertional dyspnoea in pulmonary arterial hypertension. Eur Respir Rev 2017;26(145).pii:170039. https://doi.org/10.1183/16000617.0039-2017.

  39. Sun PY, Jiang X, Gomberg-Maitland M, et al. Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension. Chest 2012;141(2):374-380. https://doi.org/10.1378/chest.10-3331.

  40. Leier CV,Young JB, Levine TB, et al. Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. Congest Heart Fail 2001;7(6):297-308.

  41. Mcnab P, Castro P, Verdejo H, Martínez G. Estimación auscultatoria de la presión sistólica de arteria pulmonar: ¿Es factible? Correlación con determinación ecocardiográfica. Rev Med Chile 2010;138(11):1351-1356.

  42. Brunk SF. Auscultatory percussion: an added dimension in physical diagnosis. Int J Clin Pract 2003;57(3):209-209.

  43. Caplin M, Moshier AL. Abnormal heart sounds: other diastolic and systolic sounds.In: Caplin M, Moshier AL, editors. Auscultation Sskills.Breath & heart sounds. 3ra ed. Ambler, PA:Williams& Wilkins; 2006.p.53.

  44. Gómez-Sáenz LM. Auscultación cardíaca. En Flores-Franco RA, Gómez-Sáenz LM, editor. La estetoscopia. Teoría, práctica y enseñanza-aprendizaje. México: Trillas; 2018.p.80.

  45. Mandel J. Approach to the patient with pulmonary hypertension. In: Mandel T, editor. Pulmonary vascular disease. Philadelphia, PA: Saunders Elsevier; 2006.p.84-85.

  46. Sandoval-Zárate J. Right ventricle insufficiency in pulmonary arterial hypertension. Physiopathologic considerations. Arch Cardiol Mex 2001;71 Suppl1:S164-S167.

  47. Bhattacharya A. Cor pulmonale. JIACM 2004;5(2):128-136.

  48. Diller GD, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115(8):1039-1050. https://doi.org/10.1161/CIRCULATIONAHA.105.592386.


2019, Number 3

2019; 78 (3)